Clinical trial
Evaluation of Safety, Performance, and Usability of the AquaPass Device in Treatment of CHF Patients
NCT05843201 is registered in ClinicalTrials.gov with AquaPass Medical Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Safety, Performance, and Usability of the AquaPass Device in Treatment of CHF Patients
- Lead sponsor
- AquaPass Medical Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 20, 2022
- Completion date
- December 12, 2023
- Enrollment
- 18 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
chf, chronic heart failure, edema